NewAmsterdam Pharma
NAMS
NAMS
76 hedge funds and large institutions have $1.71B invested in NewAmsterdam Pharma in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 2 closing their positions.
Holders
76
Holders Change
+44
Holders Change %
+137.5%
% of All Funds
1.1%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
46
Increased
13
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
GC
1
GMT Capital
Atlanta,
Georgia
|
$22.3M |
2 |
2
Millennium Management
New York
|
$22.4M |
3 |
3
Goldman Sachs
New York
|
$30.4M |
4 |
PHP
4
Parkman Healthcare Partners
Stamford,
Connecticut
|
$4.74M |
5 |
5
Axa
Paris,
France
|
$5.89M |